However, a meta-analysis of randomized clinical trials revealed that the relative risk of all grades of acute kidney injury in patients taking mTOR inhibitors is significantly higher than that in patients not taking mTOR inhibitors, indicating that renal toxicity is a potential complication of mTOR inhibitor use [33]. Here, MTOR is linked to acute kidney injury.